Shiroshita, Akihiro
Takeshita, Masafumi
Nishiuma, Teruaki
Ota, Tomoaki
Kataoka, Yuki
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K09582)
Pfizer Health Research Foundation
Ichinomiyanishi Hospital
Article History
Received: 16 March 2025
Accepted: 20 June 2025
First Online: 12 July 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review board of Showa University (approval number: 2023-119-B). The requirement for written informed consent was waived owing to the retrospective design of the study.
: Not applicable.
: This study was funded by the Japan Society for the Promotion of Science, Pfizer Health Research Foundation, and Ichinomiyanishi Hospital. The Pfizer Health Research Foundation supported the cost of data acquisition. Ichinomiyanishi Hospital supported the English editing service fee. The Japanese Society for the Promotion of Science funded the publication fee (Grants-in-Aid for Scientific Research [Kakenhi], grant number 23K09582). The funders played no role in the study design, execution, analyses, interpretation, or decision to submit the results.